Your browser doesn't support javascript.
loading
Achievement of glycaemic targets with weight loss and without hypoglycaemia in type 2 diabetes with the once-weekly glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide: A post hoc analysis of the SURPASS-1 to -5 studies.
Lingvay, Ildiko; Cheng, Alice Yy; Levine, Joshua A; Gomez-Valderas, Elisa; Allen, Sheryl E; Ranta, Kari; Torcello-Gómez, Amelia; Thieu, Vivian T.
Afiliação
  • Lingvay I; Department of Internal Medicine/Endocrinology and Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Cheng AY; Division of Endocrinology and Metabolism, Department of Medicine, Trillium Health Partners and Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada.
  • Levine JA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
  • Gomez-Valderas E; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
  • Allen SE; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
  • Ranta K; Eli Lilly and Company, Helsinki, Finland.
  • Torcello-Gómez A; Eli Lilly and Company, Cork, Ireland.
  • Thieu VT; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana.
Diabetes Obes Metab ; 25(4): 965-974, 2023 04.
Article em En | MEDLINE | ID: mdl-36514843

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insulinas / Hipoglicemia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insulinas / Hipoglicemia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article